Genmab A/S (GMAB)

Genmab Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	18,081	21,036	27,898	25,960	26,459	14,359
Market Cap Growth	-20.65%	-24.60%	7.47%	-1.89%	84.27%	35.31%
Enterprise Value	13,913	16,982	24,768	23,094	23,876	12,749
PE Ratio	22.75	32.63	35.51	57.94	33.92	44.42
PS Ratio	7.03	8.62	13.35	20.36	15.96	17.93
PB Ratio	3.81	4.49	7.10	7.72	8.44	6.85
P/FCF Ratio	23.14	20.27	53.86	86.71	26.35	79.18
P/OCF Ratio	21.91	19.24	49.49	76.90	25.09	72.55
EV/Sales Ratio	5.41	6.96	11.85	18.11	14.40	15.92
EV/EBITDA Ratio	-	-	-	-	-	29.80
EV/EBIT Ratio	11.84	17.42	22.54	32.99	19.52	29.80
EV/FCF Ratio	17.80	16.37	47.81	77.14	23.77	70.30
Debt / Equity Ratio	0.03	0.02	0.02	0.02	0.02	0.01
Debt / EBITDA Ratio	-	-	-	-	-	0.06
Debt / FCF Ratio	0.19	0.11	0.17	0.22	0.05	0.15
Quick Ratio	12.44	13.34	15.41	14.50	14.81	14.90
Current Ratio	12.46	13.34	15.48	14.50	15.00	14.88
Asset Turnover	0.51	0.50	0.51	0.36	0.51	0.47
Interest Coverage	8.12	6.98	11.21	6.58	4.79	409.43
Return on Equity (ROE)	17.60%	14.70%	21.60%	14.10%	27.20%	20.20%
Return on Assets (ROA)	15.70%	13.10%	19.30%	12.70%	24.20%	18.80%
Return on Capital (ROIC)	13.09%	12.69%	17.65%	9.85%	26.17%	14.05%
Earnings Yield	4.36%	3.06%	2.82%	1.73%	2.95%	2.25%
FCF Yield	4.32%	4.93%	1.86%	1.15%	3.80%	1.26%
Buyback Yield / Dilution	-0.17%	-0.36%	-0.32%	-0.84%	-1.20%	-
Total Shareholder Return	-0.17%	-0.36%	-0.32%	-0.84%	-1.20%	-

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).